Composition for preventing or treating inflammatory skin diseases,containing 1h-pyrazole-3-amide compound derivative
AssigneeAjou University Industry-Academic Cooperation Foundation
InventorsWook KIM, Eunha KIM, Ji Hye HAN, Hong-Seo CHOI, Eun-Su KIM, Suha KIM
Life of this patent
Estimating the term…
Abstract
The present invention relates to a composition for preventing or treating inflammatory skin diseases, containing a 1H-pyrazole-3-amide compound derivative. Found to reduce TNF-α, IL-1β, IL-17A, and Ki67 in the skin of mouse models of psoriasis or contact dermatitis, the composition can prevent or treat such inflammatory skin diseases by effectively inhibiting psoriasis or contact dermatitis.
Claims10
A method of preventing or treating an inflammatory skin disease comprising administering a pharmaceutical composition, comprising a 1H-pyrazole-3-amide compound represented by the following Chemical Formula 1 or a pharmaceutically acceptable salt thereof as an active ingredient to a subject in need of preventing or treating the inflammatory skin disease:
- wherein, in the Chemical Formula 1,
- A is
- R1 is hydrogen, (C1-C10)alkyl, (C3-C7) cycloalkyl, (C6-C20) aryl, or (C6-C20) ar (C1-C10)alkyl;
- R2 and R3 are independently hydrogen, (C1-C10)alkyl, (C6-C20) aryl, (C6-C20) ar (C1-C10)alkyl, (C3-C7) cycloalkyl, (C3-C7) heterocycloalkyl comprising one or more heteroatoms selected from N, O, and S, adamantyl, piperidino, or pyrrolidino or R2 and R3 may be connected to (C3-C7)alkylene to form a ring, and one or more carbon atoms in the alkylene may be substituted with NR6, O, or S;
- R4 and R5 are each independently hydrogen, (C1-C10)alkyl, (C3-C7) cycloalkyl, or (C6-C20) aryl;
- R6 is hydrogen, (C1-C10)alkyl, or (C1-C10)alkoxycarbonyl;
- and
- the alkyl, aryl, aralkyl, cycloalkyl, adamantly, or heterocycloalkyl in the R1, R2, and R3 may be further substituted with one or more substituents selected from halogen, (C1-C10)alkyl, halo (C1-C10)alkyl, (C1-C10)alkoxy, mono or di-(C1-C10)alkylamino, mono or di-(C6-C20) arylamino, (C3-C7) cycloalkyl, (C2-C20) heteroaryl, hydroxy, (C3-C7) heterocycloalkyl comprising one or more heteroatoms selected from N, O, and S, pyrrolidino, or piperidino.
A method of preventing or ameliorating an inflammatory skin disease comprising administering a health functional food composition;
- comprising a 1H-pyrazole-3-amide compound represented by the following Chemical Formula 1 or a pharmaceutically acceptable salt thereof as an active ingredient to a subject in need of preventing or ameliorating the inflammatory skin disease:
- wherein, in the Chemical Formula 1,
- A is
- R1 is hydrogen, (C1-C10)alkyl, (C3-C7) cycloalkyl, (C6-C20) aryl, or (C6-C20) ar (C1-C10)alkyl;
- R2 and R3 are independently hydrogen, (C1-C10)alkyl, (C6-C20) aryl, (C6-C20) ar (C1-C10)alkyl, (C3-C7) cycloalkyl, (C3-C7) heterocycloalkyl comprising one or more heteroatoms selected from N, O, and S, adamantyl, piperidino, or pyrrolidino or R2 and R3 may be connected to (C3-C7)alkylene to form a ring, and one or more carbon atoms in the alkylene may be substituted with NR6, O, or S;
- R4 and R5 are each independently hydrogen, (C1-C10)alkyl, (C3-C7) cycloalkyl, or (C6-C20) aryl;
- R6 is hydrogen, (C1-C10)alkyl, or (C1-C10)alkoxycarbonyl;
- and
- the alkyl, aryl, aralkyl, cycloalkyl, adamantly, or heterocycloalkyl in the R1, R2, and R3 may be further substituted with one or more substituents selected from halogen, (C1-C10)alkyl, halo (C1-C10)alkyl, (C1-C10)alkoxy, mono or di-(C1-C10)alkylamino, mono or di-(C6-C20) arylamino, (C3-C7) cycloalkyl, (C2-C20) heteroaryl, hydroxy, (C3-C7) heterocycloalkyl comprising one or more heteroatoms selected from N, O, and S, pyrrolidino, or piperidino.
Dependencies are inferred from the claim text.